Skip to Content
800-533-8762
  • Careers
  • Newsroom
  • Health Care Professionals
  • About Us
  • Contact Us
UPMC
  • Find a Doctor
  • Services
    • Frequently Searched Services
    • Frequently Searched Services
      Allergy & Immunology Behavioral & Mental Health Cancer Ear, Nose & Throat Endocrinology Gastroenterology Heart & Vascular Imaging Neurosciences Orthopaedics
      Physical Rehabilitation Plastic & Reconstructive Surgery Primary Care Senior Services Sports Medicine Telemedicine Transplant Surgery Walk-In Care Weight Management Women’s Health
      See all Services
    • Services by Region
    • Find a UPMC health care facility close to you quickly by browsing by region.
      UPMC in Western Pa. Western Pa. and New York
      UPMC in Central Pa. Central Pa.
      UPMC in North Central Pa. North Central Pa.
      UPMC in Western Md. Maryland & West Virginia
    • See All Services
  • Locations
    • Locations by Type
    • Locations by Type
      UPMC hospitals
      Hospitals
      Physical Therapy
      Physical Therapy
      Urgent care
      Walk-In Care
      UPMC Outpatient Centers
      Outpatient Centers
      UPMC Imaging Services
      Imaging
      Community Health Centers
      Community Health Centers
      See All Locations
    • Locations by Region
    • Locations by Region
      UPMC in Southwest Pa. Southwest Pa.
      UPMC in North Central Pa. North Central Pa.
      UPMC in Northwest Pa and Ny. Northwest Pa. & Western N.Y.
      UPMC in West Central Pa. West Central Pa.
      UPMC in Central Pa. Central Pa.
      UPMC in Western Md. Maryland & West Virginia
    • See All Locations
  • Patients & Visitors
    • Patient & Visitor Resources
    • Patient & Visitor Resources
      Patients and Visitors Resources Pay a Bill Classes & Events Medical Records Health Library Patient Information
      Patient Portals Privacy Information Shared Decision Making Traveling Patients Visitor Information
      Man uses mobile phone
      Pay a Bill
      Nurse reviews medical chart
      Request Medical Records
  • Patient Portals
  • Find Covid-19 updates
  • Schedule an appointment
  • Request medical records
  • Pay a bill
  • Learn about financial assistance
  • Find classes & events
  • Send a patient an eCard
  • Make a donation
  • Volunteer
  • Read HealthBeat blog
  • Explore UPMC Careers
Skip to Content
UPMC
  • Patient Portals
  • For Patients & Visitors
    • Find a Doctor
    • Locations
    • Patient & Visitor Resources
    • Pay a Bill
    • Services
    • More
      • Medical Records
      • Financial Assistance
      • Classes & Events
      • HealthBeat Blog
      • Health Library
  • About UPMC
    • Why UPMC
    • Facts & Stats
    • Supply Chain Management
    • Community Commitment
    • More
      • Financials
      • Support UPMC
      • UPMC Apps
      • UPMC Enterprises
      • UPMC International
  • For Health Care Professionals
    • Physician Information
    • Resources
    • Education & Training
    • Departments
    • Credentialing
  • Careers
  • Contact Us
  • Newsroom
  • UPMC >
  • Our Services >
  • Urology >
  • ... >
  • Our Experts >
  • Our Experts >
  • jan pilch
Urology
About Us
Our Services
Conditions We Treat
Our Experts
Our Research
Donate
Education & Training
Patient Resources
Contact Us
Urology
About Us
Our Services
Conditions We Treat
Our Experts
Our Research
Donate
Education & Training
Patient Resources
Contact Us

Chat Keywords List

  • cancel or exit: Stops your conversation
  • start over: Restarts your current scenario
  • help: Shows what this bot can do
  • terms: Shows terms of use and privacy statement
  • feedback: Give us feedback
Continue
Chat with UPMC
RESTART
MENU
CLOSE

Jan Pilch, MD

UPMC Content 3

Targeting Blood Clot in the Stroma of Genitourinary Cancer.

The presence of blood clot in the tumor stroma and around metastatic tumor cells has been recognized for many years. However, our knowledge about the contribution of blood clot to the function of the tumor extracellular matrix is still very limited. The research of my laboratory is aimed at (i) improving our understanding about the role of clot formation for the progression of genitourinary cancer and (ii) exploiting the presence of clot in these malignancies for targeted delivery of anti-tumor therapeutics and imaging agents.

Molecular analysis of the tumor homing peptides CLT1 and CLT2.

The tumor extracellular matrix is different from the normal connective tissue in that it contains clotted plasma proteins. The presence of clotted plasma (fibrin + cross-linked plasma proteins) in the tumor extracellular matrix is functionally connected to vascular endothelial growth factor, which causes hyperpermeability of tumor blood vessels. As a consequence, blood plasma leaks into tumor interstitial spaces where the plasma begins to clot in a manner similar to wounds. To identify small peptides that bind to the tumor extracellular matrix, we screened a phage library on clotted plasma in vitro and identified two peptides with the amino acid sequence CGLIIQKNEC (CLT1) and CNAGESSKNC (CLT2). Injected into mice, CLT1 and CLT2 accumulate strongly in the interstitial spaces of breast, prostate, kidney and skin tumors, but not in the connective tissue of normal organs. Both CLT peptides associate with fibrin-fibronectin in tumors and cease to home to tumors grown in fibrinogen and plasma fibronectin-deficient mice. In addition, we found that CLT1 is cytotoxic for tumor and proliferating endothelial cells while CLT2 has no such effects. We hypothesize that CLT1 is useful for the detection and treatment of genitourinary cancer. The objective of this project is to (1) identify amino acid residues within CLT1 critical for tumor homing and cytotoxicity; (2) identify receptor(s) on endothelial and tumor cells that mediate(s) CLT1 cytotoxicity; (3) test if CLT1 has anti-angiogenic and anti-tumor function in vivo; and (4) determine if CLT1 improves detection of genitourinary cancer by magnet resonance imaging.

Role of fibrin-fibronectin complexes for tumor metastasis.

Tumor metastasis is aided by blood clotting factors that form a thrombus consisting of platelets and clotted plasma around circulating tumor cells. We recently found that absence of plasma fibronectin (pFN), a major component of clotted plasma, leads to reduced lung metastasis by supporting adhesive interactions of tumor cell integrin αvβ3 with clotted plasma. In vitro studies showed that fibrin-fibronectin (FibFN) complexes, but not purified fibrin, support tumor cell attachment and invasion. FibFN also stimulates adhesion of monocytes, which served as a model for FibFN-mediated activation of integrin αvβ3. Paralleling these results in vivo, we found that pFN promotes co-localization of myeloid cells with circulating tumor cells. We hypothesize that FibFN binds to a novel receptor on tumor and myeloid cells and that the interaction of FibFN with its receptor promotes cell adhesion and invasion in vitro and tumor metastasis in vivo. The objective of this project is to (1) identify the FibFN binding site on tumor and myeloid cells that mediates cell adhesion, invasion and metastasis; (2) determine signaling pathways that mediate tumor cell invasion and metastasis downstream of FibFN; and (3) determine if FibFN mediates the recruitment of myeloid cells to metastatic tumor cells.

Selected Publication

1. Gunjan Malik, Lynn M. Knowles, Rajiv Dhir, Shuping Xu, Shuting Yang, Erkki Ruoslahti and Jan Pilch. Plasma fibronectin promotes lung metastasis by contributions to fibrin clots and tumor cell invasion. Cancer Research, 70(11):4327-34, 2010.

2. D. Simberg, T. Duza, J.H. Park, M. Essler, J. Pilch, L. Zhang, A.M. Derfus, M. Yang, R.M. Hoffman, S. Bhatia, M.J. Sailor, E. Ruoslahti: Biomimetic amplification of nanoparticle homing to tumors. Proc Natl Acad Sci U S A, 104(3): 932-936, 2007.

3. J. Pilch, D.M. Brown, M. Komatsu, T.A.H. Jarvinen, M. Yang, D. Peters, R.M. Hoffman, E. Ruoslahti: Peptides selected for binding to clotted plasma accumulate in tumor stroma and wounds.  Proc Natl Acad Sci U S A, 103(8):  2800-2804, 2006.

4. J. Pilch, C.M. Franzin, L.M. Knowles, F.J. Ferrer, F.M. Marassi, E. Ruoslahti: The anti-angiogenic peptide anginex disrupts the cell membrane. J Mol Biol, 356(4): 876-85, 2006.

5. M.E. Akerman*, J. Pilch*, D. Peters, E. Ruoslahti: Angiostatic peptides use plasma fibronectin to home to angiogenic vasculature. Proc Natl Acad Sci U S A, 102(6): 2040-2045, 2005.
 *M.E. Akerman and J. Pilch contributed equally

UPMC
200 Lothrop Street Pittsburgh, PA 15213

412-647-8762 800-533-8762

Patients And Visitors
  • Find a Doctor
  • Locations
  • Pay a Bill
  • Patient & Visitor Resources
  • Disabilities Resource Center
  • Services
  • Medical Records
  • No Surprises Act
  • Price Transparency
  • Financial Assistance
  • Classes & Events
  • Health Library
Health Care Professionals
  • Physician Information
  • Resources
  • Education & Training
  • Departments
  • Credentialing
Newsroom
  • Newsroom Home
  • Inside Life Changing Medicine Blog
  • News Releases
About
  • Why UPMC
  • Facts & Stats
  • Supply Chain Management
  • Community Commitment
  • Financials
  • Supporting UPMC
  • HealthBeat Blog
  • UPMC Apps
  • UPMC Enterprises
  • UPMC Health Plan
  • UPMC International
  • Nondiscrimination Policy
Life changing is...
Follow UPMC
  • Contact Us
  • Website/Email Terms of Use
  • Medical Advice Disclaimer
  • Privacy Information
  • Active Privacy Alerts
  • Sitemap
© 2025 UPMC I Affiliated with the University of Pittsburgh Schools of the Health Sciences Supplemental content provided by Healthwise, Incorporated. To learn more, visit healthwise.org
Find Care
Providers
Video Visit
Portal Login